Tango Therapeutics Inc.

TNGX | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.33

+$0.58 (+2.67%)

At close: Sep 21, 2026, 4:00 PM ET

$22.63

+$0.30 (+1.35%)

Pre-market: Sep 22, 2026, 8:06 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	62.38M	42.07M	36.53M	24.86M	37.04M	7.66M
Cost of Revenue	2.28M	n/a	n/a	n/a	n/a	1.63M
Gross Profit	60.1M	42.07M	36.53M	24.86M	37.04M	6.03M
Operating Income	-111.29M	-145.6M	-114.17M	-111.07M	-58.19M	-52.2M
Interest Income	5.63M	7.89M	6.62M	1.46M	495K	108K
Pretax Income	-101.59M	-130.09M	-101.61M	-108.12M	-57.94M	-51.97M
Net Income	-101.59M	-130.3M	-101.74M	-108.18M	-58.24M	-51.97M
Selling & General & Admin	41.51M	43.75M	35.5M	30.03M	17.6M	8.24M
Research & Development	132.17M	143.92M	115.2M	105.91M	77.64M	49.99M
Other Expenses	-2.28M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	171.39M	187.66M	150.7M	135.93M	95.23M	58.23M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	173.67M	187.66M	150.7M	135.93M	95.23M	59.86M
Income Tax Expense	4K	208K	134K	54K	292K	n/a
Shares Outstanding (Basic)	116.17M	109.23M	94.57M	87.82M	62.11M	87.47M
Shares Outstanding (Diluted)	116.17M	109.23M	94.57M	87.82M	62.11M	87.47M
EPS (Basic)	-0.87	-1.19	-1.08	-1.23	-0.94	-1.62
EPS (Diluted)	-0.87	-1.19	-1.08	-1.23	-0.94	-1.62
EBITDA	-99.31M	-127.6M	-99.2M	-106.51M	-57.05M	-50.35M
EBIT	-101.59M	-130.09M	-101.61M	-108.12M	-57.94M	-51.97M
Depreciation & Amortization	2.28M	2.5M	2.42M	1.61M	897K	1.63M